$AMBA

Young John Alexander sold $340K of AMBA

Young John Alexander (CFO) sold 5,033 shares of AMBARELLA INC (AMBA) at an average of $67.54 ($66.98–$67.87, $0.34M total) across 2 trades on 2026-06-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Young John Alexander
Published Jun 18, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 11:49 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AMBA
Neutral
medium confidence
Mentioned
$AMBA
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBANeutralLow
01

Why it matters

The disclosure confirms the CFO executed two open-market sale trades on 2026-06-17 totaling 5,033 shares at an average price of about $67.54, with holdings after the sale of 112,590 shares.

02

Market read

Traders may monitor insider activity, but 10b5-1 selling typically has limited predictive value for near-term fundamentals.

03

What to watch

The article does not state whether other insiders sold/bought around the same window, nor does it provide context on total insider ownership changes beyond the post-transaction holdings.

Relevance 3/10Novelty 3/10Timing: Filed 2026-06-18, disclosing sales executed 2026-06-17.

Background

This is an SEC Form 4 insider transaction for AMBARELLA, reported by the CFO.

Company-level read

Ticker impact

$AMBANeutralMedium confidence
Context

AMBARELLA CFO Young John Alexander sold about $339,946 of AMBA shares via an open-market sale under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any impact is likely short-lived.

Evidence & confidence

The filing is a disclosed insider sale with a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

No direct sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect liquidity planning rather than bearish fundamentals, so traders may ignore it.

Key entities

  • AMBARELLA INC

    US-listed company whose CFO insider sale is disclosed on Form 4.

  • Young John Alexander

    CFO who sold shares under a pre-arranged Rule 10b5-1 plan.

Related articles

$NXPIMedAI 8/10

Dutch company NXP considers acquiring US-based Ambarella for more than $3 billion

NXP is reportedly in talks to acquire U.S. chip designer Ambarella for more than $3 billion, according to sources cited by the Financial Times. Ambarella makes image processing chips for surveillance and automotive systems. NXP says its automotive unit is nearly half of revenue, estimated above $14 billion. Ambarella shares rose, valuing it around $4 billion.

$AMBAMed

Why is Ambarella stock surging today?

Ambarella shares rose 19.2% intraday after the Financial Times reported NXP Semiconductors is in ongoing discussions to acquire Ambarella. Talks are described as active but not finalized. The article cites Ambarella’s edge AI growth, including 37% fiscal 2026 revenue growth and Edge AI revenue up 50% to 80% of sales, and notes Stifel’s Buy rating and $106 target.